Parkview Health and MATTER announce finalists for the Healthy Mom & Baby Innovation Competition 2.0
NUA Surgical leads finalist cohort into accelerator program
Five finalists have been announced in the 2021 Healthy Mom and Baby 2.0 Innovation Competition. The contest is a collaborative effort of Parkview Health, a not-for-profit, community-based health system serving more than 895,000 people in northeast Indiana and northwest Ohio, and MATTER, the premier healthcare incubator and innovation hub. The five finalists will advance to an accelerator program focused on refining their solutions and preparing a pilot proposal.
“We need innovation in healthcare to bring new products and solutions to our patients and advance care in our region,” said Dr. Michael Mirro, SVP and chief academic research officer of Parkview Health. “That’s just what the innovators in this competition are doing and why we’re so excited to work with them.”
“We need innovation in healthcare to bring new products and solutions to our patients and advance care in our region.” — Dr. Michael Mirro, Parkview Health
The pitch competition was judged by a group of Parkview stakeholders and community leaders throughout Indiana, all focused on maternal and infant health. The distinguished jurists selected NUA Surgical, a novel Caesarean-section (C-section) retractor solution out of Galway, Ireland, as the winner of the innovation competition with an award of $10,000 and advancement to the accelerator phase.
“We are thrilled to win the semi-finalist pitch competition. The most satisfying aspect is that the competition was judged by innovation experts and leaders in the field of maternal and infant health. It is extremely rewarding to have future end-users of your innovation speak so highly of it. Their support further validates that the innovation we are working on is desperately needed in the surgical theatre. We look forward to working closely with Parkview Health and MATTER during the accelerator in the coming months,” said CEO of NUA Surgical Barry McCann.
“It is extremely rewarding to have future end-users of your innovation speak so highly of it. Their support further validates that the innovation we are working on is desperately needed in the surgical theatre.” — Barry McCann, NUA Surgical
MaMome, a company focused on the early identification of high-risk pregnancies based on the bacterial composition of the maternal microbiome, was voted as the audience favorite.
The two-month accelerator program run by MATTER in conjunction with Parkview Health will see teams continue to build and test their solutions. During the final pitch competition on December 15, 2021, finalists will present their refined solutions and ideas for potential pilots to a community of healthcare professionals, Parkview leaders and outside investors. All teams who participate in the final pitch day will receive a one-year global membership at MATTER.
The finalists are:
BleedID — Orlando, Florida
BleedID is a real-time blood loss detection device. It solves the problem of unrecognized bleeding that can occur under the surgical drape, while alerting the operating team of critical blood loss thresholds.
JioVio Healthcare — Tamilnadu, India
JioVio Healthcare provides an end-to-end solution that ensures the availability of high-quality maternal care for mothers in remote places. JioVio provides personalized and predictive maternal care using AI, IoT and wearable technology. They have devised an easy method to collect critical maternal data digitally.
LiquidGoldConcept — Ypsilanti, Michigan
LiquidGoldConcept addresses the global shortage of timely and skilled lactation support for mothers by providing best-in-class lactation education to health professionals using their groundbreaking simulation technology. They manufacture newborn, breast health and breastfeeding simulators in four skin tones and incorporate that technology into tele-simulations, where health professionals engage in live clinical practice over video calls with mock patients. Their education solutions dramatically improve health professionals’ clinical competence in prenatal and postpartum care.
Maternal 911 — Ithaca, Michigan
Maternal 911’s safety program is a 100% online education course for any healthcare professional that’s working with pregnant, laboring or postpartum women. This program provides evidence-based education to ensure safe, quality care is provided to every woman, all the time. Women can now be fully confident in their healthcare team.
NUA Surgical — Galway, Ireland
A consequence of the global obesity epidemic is that many of the 29 million C-sections performed each year face a major challenge in that exposure of the uterus is obstructed by excess abdominal tissue. This often leads to longer surgeries with a higher rate of infant and maternal complications. NUA Surgical has developed the SteriCISIONTM C-Section Retractor, a device ergonomically designed for the obstetrician and their assistant, allowing hands-free unobstructed access to the uterus and delivering safer outcomes for mother and baby.
Register to hear more from each of these companies on December 15, 2021.
About Parkview Health
Parkview Health is a not-for-profit, community-based health system serving a northeast Indiana and northwest Ohio population of more than 895,000. With more than 13,000 employees, Parkview is the region’s largest employer.
Parkview Health includes 10 hospitals and an extensive network of primary care and specialty care physicians. Parkview has been named one of America’s Best Large Employers by Forbes magazine and has been designated a Magnet® health system for nursing excellence.
About MATTER
At MATTER, we believe collaboration is the best way to improve healthcare. The MATTER collaborative includes more than 200 cutting-edge startups from around the world, working together with dozens of hospitals and health systems, universities and industry-leading companies to build the future of healthcare. Together we are accelerating innovation, advancing care and improving lives. For more information, visit matter.health and follow @MATTERhealth.